Foreign animal disease outbreaks can cause substantial economic losses. Policy makers need information on both the vulnerability of the food supply to disease epidemics and the impacts of alternative protection actions. This research focused on the assessment of the U.S. agricultural sector and human vulnerability to a Rift Valley Fever (RVF) outbreak and the value of a select set of alternative disease control strategies. RVF is a vector-borne, zoonotic disease that affects both livestock and humans; thus both animal and human consequences of an outbreak were examined. This research was conducted in two parts. Livestock impact assessment used an integrated epidemic/economic model to examine the extent of RVF spread in the animal population and its consequences plus the outcome of implementing two different control strategies: emergency vaccination and larvicide vector control. The number of infected, aborted, and dead animals is best controlled by coupling vaccination along with larvicide, but results in the second highest median national welfare loss. Therefore, careful decisions must be made as to what actions should be taken. Total national producer welfare is reduced with each scenario, and is more severe than the total national welfare loss (producer, consumer, and processor together). Consumer welfare is increased with each scenario due to a drop in prices of some commodities, and in some instances, an increase in supply as well. The majority of the national welfare loss can be attributed to the producers' and processors' loss in welfare. The highest damages are seen in the regions of the outbreak such as the South Central (SC). Other regions such as the Corn Belt, Lake States, and South East regions also see high damages due to price changes. The outbreak did not have substantial price effect on dairy products, but did have noticeable price changes for live cattle such as heifer calves, stocked yearling, and dairy calves. Prices for substitutes such as pork, chicken, and turkey experienced a price reduction, which can also be a factor resulting in consumer welfare gains. Human impact assessment utilized an inferential procedure for estimating the human consequences which comprise of a cost of illness calculation to assess the dollar cost of human illnesses and deaths, as well as a Disability Adjusted Life Year calculation to give an estimate of the burden of disease on public health as a whole. With potential costs above $2 billion for human illness, and with this number not accounting for loss or damages to other sectors of the economy, it can be highly probable that investing in a human vaccination campaign can be cost-effective and possibly cost-reducing. This cost along with the economic loss of the agriculture sector suggests substantial potential losses to the U.S. if this hypothetical situation were to become reality. Combining total loss estimates from the cost of illness and ASM models, potential damage of a RVF outbreak could range from 121 million to 2.3 billion US 2010$. The results of this study show the economic damages of an outbreak in the livestock population being much greater relative to the outbreak in the human population (roughly 16 times greater). It should be pointed out that both cost estimates are most likely under estimated. The animal outbreak is not incorporating all susceptible livestock (e.g. hogs and goats), and the human illness is not incorporating other damages to society (e.g. damages due to loss of tourism). By providing estimates on the potential economic outcomes, policy makers can better choose where, when, and how to invest their resources.

La fièvre de la Vallée du Rift (FVR) est une zoonose due à un virus transmissible par une large variété de vecteurs. Au cours des quinze dernières années, elle a rendu malades des dizaines de milliers de personnes, entrainé des centaines de décès humains et provoqué la mort de plus de 100 000 ruminants domestiques en Afrique et dans la péninsule arabique. Suite à la découverte de la présence du virus à Mayotte, les autorités sanitaires, le Cirad (Centre de coopération internationale en recherche agronomique pour le développement) et les éleveurs ont créé en 2009 un système de surveillance en santé animale, le SESAM. L‘objectif de cette thèse était de faire un état des lieux de la situation épidémiologique de la FVR chez les ruminants à Mayotte en 2012-2013, d’évaluer les perspectives de persistance de la maladie et d’étudier les perceptions et les priorités des éleveurs vis-à-vis de cette maladie. En 2012, le fonctionnement du dispositif de surveillance de la FVR a été révisé avec un renouvellement partiel du groupe d’éleveurs sentinelles et un renforcement de la surveillance événementielle basée sur la recherche systématique de la FVR en cas d’avortement ou de mortalité anormale. Une baisse continue de la séroprévalence de 2010 à 2013 a été observée. En 2012-2013, le taux d’incidence est resté stable avec environ deux séroconversions pour 100 animaux-ans. Ce taux est très inférieur au taux d’incidence de 18% observé en 2011. Le virus de la FVR n’a été détecté dans aucun des prélèvements réalisés dans le cadre de la déclaration officielle des avortements chez les ruminants (n=41). Des critères d’évaluation de la performance du dispositif de surveillance ont été proposés et ont mis en évidence une amélioration de la qualité des données entre 2010 et 2013. Un modèle dynamique de type SIR a permis d’estimer le niveau de transmission hôte-vecteur attendu qui expliquerait au mieux la séroprévalence observée de 2008 à 2013 à Mayotte. La probabilité de transmission hôte-vecteur estimée par ce modèle est cinq fois plus faible qu’attendue. Dans ces conditions, la probabilité de persistance de la FVR, en l’absence de nouvelle introduction d’animaux virémiques reste inférieure à 10%, cinq ans après l’arrivée du virus. Enfin, la priorisation des problèmes sanitaires à Mayotte par une démarche d’épidémiologie participative et des réunions d’éleveurs a mis en évidence que les cinq problèmes spontanément rapportés comme les plus importants chez les bovins sont dans l’ordre le charbon symptomatique, les tiques, le syndrome « bavite-fièvre-grippe», le syndrome « dermatophilose-boutons » et la diarrhée. La FVR est absente de ce classement mais les avortements arrivent en 9ème position et à la première selon le critère de « risque ». La surveillance, et les approches interdisciplinaires de modélisation et de sciences humaines doivent être poursuivies pour évaluer plus précisément le risque de réémergence de la FVR à Mayotte et anticiper les réponses à y apporter. La surveillance doit aussi s’adapter aux attentes des éleveurs et développer l’approche syndromique ainsi que s’intégrer pleinement aux dispositifs régionaux et nationaux. / Rift Valley fever (RVF) is a vector-borne zoonosis, with a wide variety of potential competent vectors. During the last fifteen years, RVF caused tens of thousands of human cases, hundreds of human deaths and more than 100,000 domestic ruminant deaths in Africa and in the Arabic peninsula. After the first detection of RVF in Mayotte, an animal health surveillance network has been created in 2009, namely the SESAM. The aim of this PhD was to assess the epidemiological situation of Mayotte toward RVF in 2012-2013, to assess the persistence probability of RVF in the territory and to document farmers’ perceptions and health priorities. In 2012, RVF surveillance has been revised in order to partially renew the pool of the sentinel herds. The passive surveillance with systematic RVF detection assay on abortion and abnormal mortality was enforced. A continuous decrease in the seroprevalence was observed based on 2010-2013 data. During 2012-2013, a steady incidence rate of about 2 seroconversions per 100 animal-year was observed. This rate is much lower than the previous assessment of 18% during 2011. RVF virus was not detected in any of the 41 declared abortion cases. Surveillance performance criteria were discussed and assessed showing mainly an increase in data quality between 2010 and 2013. A SIR dynamic model was built based on vector knowledge and observed seroprevalence in Mayotte from 2008 to 2013. Estimated host-vector transmission rate was fivefold lower than expected according to current literature. Persistence probability, without reintroduction of viremic animals, was predicted to be 10% five years after virus introduction. Finally, health problem prioritization in Mayotte was studied through focus groups, gathering 164 farmers. The five main issues stated were: blackleg, ticks, a respiratory « fever/flu-like» syndrome, a dermatologic syndrome and diarrhoea. RVF was absent from the priority problems list in which abortions were ranked 9th. However abortions came first when « risk » criteria was taken into account, raising issues of cultural risk perceptions. Further surveillance and research using transdisciplinary approaches that mix mathematical modelling and the humanities should be continued with the view to assess more precisely reemergence probability in Mayotte and anticipate mitigating measures. Surveillance and research should also align with farmers’ expectations. The development of syndromic surveillance (abortion, death, etc.) requires strengthening surveillance network and identification data quality. Mayotte surveillance components should also be fully integrated within the regional and national schemes.

Bunyaviridae is one of the biggest known viral families, and includes many viruses of clinical and economic importance. The major virulence factor of most bunyaviruses is the non-structural protein (NSs). NSs is expressed early in infection and inhibits the innate immune response of the host by blocking several steps in the interferon induction and signalling pathways. Hence, NSs significantly contributes to the establishment of a successful viral infection and replication, persistent infection and the zoonotic capacity of bunyaviruses. Although functions and structures of many viral interferon antagonists are known, no structure of a bunyavirus NSs protein has been solved to date. This strongly limits our understanding of the role and the mechanism of interferon antagonism in this large virus family. In this work the first structure for a bunyavirus interferon antagonist, the core domain crystal structure of NSs from the Rift Valley fever virus (RVFV) is presented. RVFV is one of the most clinically significant members of the Bunyaviridae family, causing recurrent epidemics in Africa and Arabia, often featuring high-mortality haemorrhagic fevers. The structure shows a novel all-helical fold. The unique molecular packing of NSs in the crystal creates stable fibrillar networks, which could correspond to the characteristic fibrillation of NSs observed in vivo in the nuclei of RVFV infected cells. This first NSs structure might be a useful template for future structure-aided design of drugs that target the RVFV interferon antagonism. Attempts at characterising other bunyavirus NSs proteins of other genera were made, but were hampered by problems with obtaining sufficient amounts of soluble and folded protein. The approaches that proved unsuccessful for the solubilisation of these NSs proteins, however, should inform future experiments aimed at obtaining recombinant NSs for structural studies.

The aim of this study was to investigate the epidemiology of Rift Valley fever (RVF) in South Africa. The first part of the study consisted of the compilation of a full history of RVF in South Africa. This was done by compiling all references to outbreaks of the disease in South Africa from all available literature, annual reports, disease reports and animal disease databases. The geographic location and temporal occurrence of each outbreak was recorded as accurately as allowed by the available records. The result was a better and more complete picture than has hitherto been available of the spatial and temporal distribution of RVF for the period 1950, when the disease was first recognised in South Africa, to 2010. Several smaller outbreaks not mentioned in the literature were found. It emerged that large outbreaks occur in the Free State Province, Eastern Cape Province and Northern Cape Province with long periods of absence and smaller outbreaks occur in KwaZulu-Natal, Mpumalanga and Gauteng at more frequent intervals.The second part of the study used the data collected during the first part of the study to determine which climatic and other environmental factors could have played a role in the occurrence of RVF in South Africa. Multiple logistic regression analysis was used to estimate associations between the various potential risk factors and the occurrence of Rift Valley fever.The study found that the El Niño/Southern Oscillation influence on rainfall in South Africa has an effect on the occurrence of RVF in South Africa which is opposite to the effect that has been described for Kenya. A positive Southern Oscillation Index (La Niña) increases the likelihood of a RVF outbreak in South Africa.The study also found that very high rainfall during the summer months (December to February) is an important risk factor for the occurrence of RVF and it confirmed the increased risk of an outbreak where pans and wetlands are present as reported in several articles and disease reports on past outbreaks. Several other factors, such as minimum and maximum temperature were also found to have a statistically significant effect on the occurrence of Rift Valley fever. Copyright / Dissertation (MSc)--University of Pretoria, 2011. / Production Animal Studies / unrestricted

No description available.

Rift Valley fever virus (RVFV) is a negative-sense RNA virus that is classified as an overlap select agent by the USDA and the HHS. It was first discovered in the Rift Valley of Kenya in the early 1930s. RVFV is an arbovirus that is transmitted by mosquitoes and infects ruminants and humans. RVFV in humans causes an acute self-limiting febrile illness but in a small percentage of cases, a severe version is noted by ocular disease, hepatitis, hemorrhagic fever, and death. In ruminants, the disease is similar with young livestock being the most susceptible. RVFV is also known to cause "abortion storms" where infected pregnant ruminants abort their fetuses with a near 100% fatality rate. Viruses are obligate intracellular parasites utilizing host-factors to replicate. This study identified three host-protein interactors of the viral Gn and L proteins that aid in viral replication. UBR4 was determined to be an interactor of Gn via immunoprecipitation followed by either LC/MS/MS or western blot analysis. Its inhibition via siRNA or CRISPR-Cas9 knockout showed a reduction of viral titers and viral RNA production. It was determined that UBR4 specifically affects viral RNA production and not entry or egress. Conversely, CK1α and PP1α were identified as binding partners of the L protein using similar methods. CK1α, a kinase, and PP1α, a phosphatase, were chosen for further verification due to data demonstrating the L protein is phosphorylated on at least one serine residue, in addition to PP1α already being shown to impact RVFV replication. Inhibition of CK1 and PP1 via small molecule inhibitors, D4476 and 1E7-03, respectively, showed a decrease in viral titers and RNA production. Strand-specific RT-qPCR demonstrates that CK1 and PP1 impact genomic replication. Upon treatment with D4476 a decrease in L protein phosphorylation was observed. Additionally, it has already been shown that treatment with 1E7-03 increases L protein phosphorylation. These data indicate that CK1 and PP1 modulate L protein phosphorylation, contributing to changes in RVFV replication. This study identifies three host-proteins that affect viral replication, which could be used as a foundation for host-based therapeutic and vaccine development. / Doctor of Philosophy / Rift Valley fever virus (RVFV) is a major biological threat due to its ability to infect both livestock and humans and be passed by mosquito bite. RVFV was first discovered in Africa in the early 1930s. To date, there is no approved therapeutic or vaccine. RVFV usually causes very mild disease but in a small percentage of cases, it progresses to include liver disease, vision loss, swelling of the brain, bleeding, and death. A virus itself is not alive; it needs a living host in order to replicate. To do this, it utilizes things naturally occurring inside the host. The purpose of this study is to identify host-factors that the virus uses in order to efficiently make more viruses. The first viral protein of interest is the glycoprotein, Gn, which is important for viral entry and assembly of the viral particles. It was determined that the host-protein UBR4 is an interactor of Gn and that the inhibition of UBR4 decreases the amount of infectious virus being produced. Similarly, the host-proteins, CK1α and PP1α, were found to be interactors of the viral L protein. The L protein is responsible for synthesizing the building blocks of the virus. It was determined that when CK1 and PP1 are inhibited, the L protein is less efficient at making these building blocks. Understanding the host-factors the virus utilizes is important to the basic understanding of how RVFV infects the host and the development of therapeutics to combat an outbreak.

Le Virus du Nil Occidental (VNO) et le Virus de la Fièvre de la Vallée du Rift (VFVR) sont deux arbovirus transmis par le moustique Culex pipiens comprenant deux biotypes: pipiens et molestus. Au cours de ce projet, nous avons évalué la circulation du VNO au Liban dans des populations de moustiques, des humains, des chevaux et des poulets. Nous avons aussi évalué la compétence vectorielle des populations locales de Cx. pipiens à transmettre le VNO et le VFVR.Des moustiques ont été récoltés et testés pour la présence d’un gène spécifique du VNO. En plus, des sérums humains, de chevaux et de poulets ont été analysés pour rechercher des anticorps spécifiques par ELISA puis confirmés par neutralisation. En outre, des spécimens de Cx. pipiens ont été infectés avec la lignée 1 du VNO ou la souche de VFVR Clone 13. Ensuite, les taux d’infection, de dissémination et de transmission ont été déterminés à différents jours après infection des moustiques. La compétence vectorielle a été comparée entre les différents biotypes.Les résultats entomologiques ont révélé que Cx. pipiens est dominant (87.2%). Tous les moustiques analysés étaient négatifs pour le VNO. Les taux de séroprévalence étaient de 1.01% et 1.98% parmi les humains et les chevaux respectivement. De plus, Cx. pipiens s’est révélé bien plus compétent pour transmettre le VNO que le VFVR. Le biotype molestus est capable de transmettre le VNO plus tôt que celui de pipiens. Cette étude présente des preuves sur une faible circulation du VNO au Liban. Cx. pipiens s’est révélé compétent pour assurer cette transmission. Ainsi, il est essentiel d'établir des programmes de surveillance pour prévenir les éventuelles épidémies. / West Nile virus (WNV) and Rift Valley Fever virus (RVFV) are two emerging arboviruses that have never been reported in Lebanon. They can be transmitted by Culex pipiens mosquito species including two biotypes: pipiens and molestus. During this project, we assessed the circulation of WNV among mosquitoes, human, horse and chicken populations in Lebanon. Moreover, we evaluated, under experimental conditions, the capacity of local Cx. pipiens biotypes to transmit both viruses.Adult mosquitoes were collected, identified and tested to detect WNV RNA. Besides, human, horse and chicken blood samples were collected and screened for WNV antibodies using an in-house ELISA and then confirmed by neutralization assay. Moreover, local Cx. pipiens specimens were experimentally infected with WNV lineage 1 or RVFV Clone 13 strain. The viral infection, dissemination and transmission were then estimated at different days post infection.The vector competence was compared between Cx. pipiens biotypes.Entomological results revealed that 87.2% of collected adult mosquitoes were Cx. pipiens. Screened mosquitoes were negative for WNV. Seroprevalence rates were 1.01% and 1.98% among humans and horses respectively. Besides, local Cx. pipiens were highly competent for WNV transmission and to a lesser extent to RVFV. The molestus biotype was able to transmit WNV earlier than pipiens biotype.The present study provides new evidence of a low circulation of WNV among human and horses in Lebanon. Cx. pipiens is the suspected vector and is experimentally competent to ensure transmission. Therefore, there is a need to establish surveillance program to predict and prevent potential outbreaks.

La fièvre de la Vallée du Rift (FVR) est une arbovirose zoonotique décrite pour la première fois en 1930 au Kenya. Transmise principalement entre ruminants par des moustiques des genres Aedes, Culex et Anopheles, elle peut aussi se transmettre à l'homme par contact direct avec des produits d'avortement ou des fluides corporels d'animaux virémiques. Cette maladie a été décrite dans de nombreux pays d'Afrique ainsi que sur la péninsule arabique et dans l'Océan Indien. La circulation du virus de la FVR (VFVR) a été décrite dans 3 écosystèmes distincts : (i) les zones semi-arides sud- et est-africaines, (ii) les mares temporaires des zones arides, (iii) les zones irriguées adjacentes à de grands fleuves. Au sein de chacun de ces écosystèmes, le rôle des mouvements d'animaux dans l'introduction du VFVR et des moustiques vecteurs dans sa transmission ont fortement été mis en avant. Malgré l'existence de modèles statistiques pouvant prédire l'émergence du VFVR en Afrique de l'est notamment grâce au niveau de pluviométrie, les mécanismes de transmissions en jeu dans les autres régions sont encore incertains. L'apparition de foyers dans un écosystème tempéré et montagneux de Madagascar, où les espèces et abondances vectorielles ne sont pas favorable à la persistance du VFVR, suscite des interrogations quant à ces mécanismes. L'objectif de cette thèse est d'identifier les facteurs et les processus épidémiologiques permettant la circulation récurrente du VFVR dans un écosystème tempéré de Madagascar. L'étude a pris en considération les pratiques socio-économiques ainsi que les principaux moustiques vecteurs du virus de la zone tempérée des hautes terres malgaches. Les principaux modes de diffusion du virus entre bovins ont été étudiés au cours de 3 années de suivi sérologique. Un modèle mathématique calibré sur la base de nombreuses données empiriques collectées dans cette zone est proposé. Deux pratiques commerciales ont pu être distinguées : le commerce classique et une pratique traditionnelle de troc. Les résultats de l'analyse suggèrent une implication différente de ces deux pratiques dans la circulation du VFVR. Alors que le commerce pourrait permettre l'introduction du virus, la pratique du troc serait quant à elle le support de la circulation au sein de la zone. Un modèle déterministe est construit afin de comparer quatre scénarios pouvant expliquer la circulation virale dans cet écosystème peu favorable. Les résultats suggèrent que, si la transmission vectorielle reste la principale voie de transmission dans cet écosystème inhabituel, la transmission directe lors du vêlage de vaches virémiques pourrait également jouer un rôle. La circulation du VFVR est de plus favorisée par les pratiques socio-économiques de la zone qui permettent, malgré la saison sèche, l'exposition des bovins introduits et potentiellement virémiques aux moustiques vecteurs. / Rift Valley fever (RVF) is a zoonotic disease first described in 1930 in Kenya. Primarily transmitted between ruminant by mosquitoes of Aedes, Culex and Anopheles genus, it can also be transmitted to humans by direct contact with abortion products or body fluids of viraemic animals. This disease has been described in many African countries, in the Arabian Peninsula and the Indian Ocean. The circulation of RVF virus (RVFV) has been reported in three ecosystems: (i) semi-arid areas of South and East Africa, (ii) temporary ponds in arid areas, (iii) irrigated areas near large rivers. Within each of these ecosystems, the role of animal movements in the introduction of RVFV and that of mosquitoes in virus transmission has been strongly emphasized. Despite the existence of statistical models that predict the emergence of RVFV in East Africa based on rainfall level, the transmission mechanisms involved in other areas are still uncertain. The occurrence of an outbreak in a temperate and mountainous ecosystem of Madagascar, where the species and vector abundances are unfavorable to the persistence of RVFV, raises questions about these mechanisms.The objective of this thesis is to identify the factors and the epidemiological processes that support the RVFV recurrent circulation in a temperate ecosystem of Madagascar. The study took into account the socio-economic practices as well as major mosquito vectors of the area. The main modes of virus spread between cattle were studied during a three years serological follow-up. A mathematical model was elaborated and calibrated using empirical and field data collected in the area. Two cattle exchange practices could be distinguished: the usual trade and a traditional practice of barter. The results of the analysis suggest a different impact of these two practices in RVFV circulation. While trade may allow virus introduction, the barter practice would support its spread within the area. A deterministic model was built to compare four scenarios that could explain the recurrent virus circulation in this unfavorable ecosystem. Results suggest that, if the vector-based transmission remains the main transmission mode, direct transmission from viremic cows at calving could also play a role. RVFV circulation is favored by socio-economic practices of the area that led, despite the dry season, to the exposure of introduced, and potentially viremic, cattle to vectors.

Transmis par les moustiques, le virus de la fièvre de la vallée du Rift (vFVR) est un virus zoonotique qui affecte principalement les ruminants en Afrique et conduit à des pertes économiques importantes. Il n’existe actuellement pas de traitements et les seuls vaccins disponibles sont à usage vétérinaire. Le développement de nouveaux vaccins plus sûrs contre le vFVR est une priorité de l’OMS en raison du risque d’émergence de cet arbovirus dans d’autres continents. Dans cette étude, nous avons développé une vaccination à ADN optimisée contre le vFVR qui consiste à administrer par voie cutanée un plasmide codant pour l’ectodomaine de la glycoprotéine de surface Gn du vFVR (eGn) en présence d’un plasmide adjuvant codant le GM-CSF et combinée avec une électroporation. De plus, nous avons également optimisé la vaccination à ADN en l’associant à la stratégie de ciblage des cellules dendritiques (DCs) via un plasmide qui code des fragments d’anticorps scFv fusionnés avec l’eGn dirigés contre les récepteurs DEC205 et CD11c exprimés à la surface des DCs. Les vaccins ont été testés chez le mouton, hôte naturel du virus et dans le modèle murin pour étudier les mécanismes de protection. Dans nos deux modèles d’études, l’immunisation par le plasmide codant l’eGn confère une meilleure protection après une épreuve virale ainsi qu’une forte production d’anticorps non neutralisants par rapport au ciblage des DCs. En revanche, le ciblage d’eGn vers des récepteurs de DCs protège partiellement contre une épreuve virale et induit une immunogénicité différente dans les deux espèces. Nous avons confirmé le rôle protecteur de ces anticorps anti-eGn par un transfert passif dans le modèle murin et le mécanisme d’action de ces anticorps protecteurs reste encore à être déterminé. Notre étude montre pour la première fois la protection par un vaccin à ADN contre le vFVR chez le mouton. / The Rift valley fever virus (RVFV) is a mosquito-borne virus that mainly affect ruminants in Africa, resulting in economic burden. There is currently no treatment and only vaccine for veterinary use against the RVFV are available. The development of new and safer vaccine is urgently needed due to the risk of introduction of this arbovirus to other continents. In the present work, we developed an optimized DNA vaccination against RVFV using a plasmid encoding the ectodomain of surface glycoprotein Gn (eGn) of RVFV into the skin with plasmid adjuvant encoding GM-CSF and electroporation in sheep. We further optimized the DNA vaccination using dendritic cell targeting strategy with a plasmid encoding a single chain fragment variable (scFv) fused with eGn directed to two DC receptors, DEC205 and CD11c. The efficacy of the vaccines were tested in the sheep, the natural host and in the mouse model to investigate the mechanism of protection. In both models non-targeted eGn vaccine confer a better clinical protection and higher non-neutralizing antibody production than DC-targeted vaccine. However, in both models eGn targeting to DEC205 differentially affected the immune response and induced a partial protection after a challenge. We further demonstrated that non-neutralizing antibodies induced by native eGn protect mice by passive transfer. The mechanism mediated by these antibodies remains to be investigated. Overall, this work indicates the proof of concept that DNA vaccine can confer protection against the RVFV in the sheep.

Rift Valley fever (RVF) is an emerging viral zoonosis that causes frequent outbreaks in east Africa and on the Arabian Peninsula. The likelihood of RVF global expansion due to climate change and human anthropogenic factors is an important issue. The causative agent, RVF virus, is an arbovirus that is transmitted by several mosquito species and is able to infect a wide range of livestock as well as people. The infection leads to mass abortions and death in livestock and a potentially deadly hemorrhagic fever in humans. RVF has severe socio-economic consequences such as animal trade bans between countries, disruption of food security, and economic disaster for farmers and pastoralists as well as for countries. Human behavior such as direct contact with infected animals or their fluids and exposure to mosquito bites increases the risk for contracting the disease. To better understand the challenges associated with RVF outbreaks and to explore prevention and control strategies, we used the One Health approach. The local community had to be involved to understand the interaction between the environment, animals, and humans. We focused on Sudan, Saudi Arabia, and Kenya. First, we systematically reviewed the literature and then we performed cross sectional community-based studies using a special One Health questionnaire. Climatic and remote sensing data were used in combination with statistics to develop a sub-region predictive model for RVF. For both Saudi Arabia and Sudan, the ecology and environment of the affected areas were similar. These areas included irrigation canals and excessive rains that provide an attractive habitat for mosquito vectors to multiply. The surveillance systems were unable to detect the virus in livestock before it spread to humans. Ideally, livestock should serve as sentinels to prevent loss of human lives, but the situation here was reversed. Differences between countries regarding further spread of RVF was mainly determined by better economic and infrastructure resources. In Sudan, there was a lack of knowledge and appropriate practices at the studied community regarding RVF disease symptoms and risk factors for both animals and humans. The community was hesitant in notifying the authorities about RVF suspicion in livestock due to the lack of a compensation system. The perceived role of the community in controlling RVF was fragmented, increasing the probability of RVF transmission and disease. In Kenya, our study found that better knowledge about RVF does not always translate to more appropriate practices that avoid exposure to the disease. However, the combination of good knowledge, attitudes, and practices may explain why certain communities were less affected. Strategies to combat RVF should consider socio-cultural and behavioral differences among communities. We also noticed that RVF outbreaks in Kenya occurred in regions with high livestock density exposed to heavy rains and wet soil fluxes, which could be measured by evapotranspiration and vegetation seasonality variables. We developed a RVF risk map on a sub-regional scale. Future outbreaks could be better managed if such relevant RVF variables are integrated into early warning systems. To confront RVF outbreaks, a policy is needed that better incorporates ecological factors and human interactions with livestock and environment that help the RVF pathogen spread. Early detection and notification of RVF is essential because a delay will threaten the core of International Health Regulations (IHR), which emphasizes the share of information during a transboundary disease outbreak to avoid unnecessary geographical expansion.